pharmabiz.com The sales in North America declined to Rs.689 crore from Rs.2,093 crore in the same quarter of last year as it included sales of two exclusivity viz., ato...
Monthly Prescribing Reference Merck announced that the FDA has approved Liptruzet (ezetimibe and atorvastatin ) tablets for the treatment of elevated low-density lipoprotein (LDL) cholesterol in patient with primary or mixed hyperlipidemia as adjunctive therapy to diet when diet ...
PharmaTimes The agency has approved Liptruzet (ezetimibe and atorvastatin ) tablets for the treatment of elevated low-density lipoprotein (LDL) cholesterol in patients with primary or mixed hyperlipidaemia as adjunctive therapy to diet. Taken once-daily, Merck says ...
Medscape Dallas, Texas— The US Food and Drug Administration (FDA) has approved a new lipid-lowering combination tablet that includes atorvastatin , which went off patent in 2011, and ezetimibe (Zetia, Merck/Schering-Plough. The combination, known as Liptruzet, ...
DailyFinance LIPTRUZET (pronounced LIP-true-zett) contains ezetimibe, an efficacious LDL cholesterol lowering therapy, and atorvastatin , currently one of the most wide...
Wall Street Journal Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved LIPTRUZET(TM) (ezetimibe and atorvastatin ) tablets for the treatment of elevated low-density ...
Worcester Telegram ... five blockbuster drugs that have recently become available as generics: Actos (pioglitazone), for diabetes; Lexapro (escitalopram), an antidepressant; Lipitor ( atorvastatin ), for high cholesterol; Plavix (clopidogrel), a blood thinner; and ...
ConsumerReports.org It recently approved the combination of the popular statin drug Lipitor ( atorvastatin ) with another medication called Zetia (ezetimbe). But our medical advisers say the new product, Liptruzet, is too risky and too expensive. A single Liptruzet pill ...
7thSpace Interactive (press release) Patients were divided into two groups: patients who were commenced on atorvastatin 40 mg daily for two months followed by an individually matched dose of 10 or 20 mg/day (group A), and patients who were treated according to current recommendations ...
PipelineReview.com (press release) LIPTRUZET (pronounced LIP-true-zett) contains ezetimibe, an efficacious LDL cholesterol lowering therapy, and atorvastatin , currently one of the most widely prescribed statins in the U.S.[1] Once-daily LIPTRUZET treats two sources of cholesterol by ...
